Sigyn Therapeutics (SIGY) Change in Inventory (2016 - 2020)
Sigyn Therapeutics (SIGY) posted Change in Inventory of -$1800.0 for Q3 2020, down 584.41% sequentially from -$263.0 in Q1 2020, and up 76.19% YoY from -$1021.6 in Q4 2019.
Sigyn Therapeutics (SIGY) Change in Inventory (2016 - 2020) Analysis & Trends
Sigyn Therapeutics has reported Change in Inventory for 5 years, with the latest figure at -$1800.0 in Q3 2020.
- Quarterly Change in Inventory rose 76.19% year-over-year to -$1800.0 in Q3 2020, while the trailing twelve-month figure through Sep 2020 was -$105994.0 (down 235.91% YoY) and the FY2019 annual result came in at -$135485.0, down 5223.58% from the prior year.
- Change in Inventory declined to -$1800.0 in Q3 2020 per SIGY's latest filing, from -$263.0 in the prior quarter.
- Over five years, Change in Inventory peaked at $4400.0 in Q3 2017 and troughed at -$103931.0 in Q4 2019.
- A 5-year average of -$9939.9 and a median of -$1701.5 in 2016 frame the typical range for Change in Inventory.
- The sharpest annual moves came in 2017 and 2019: Change in Inventory surged 177.98% in 2017, then sank 1574900.0% in 2019.
- Over 5 years, Change in Inventory stood at -$1603.0 in 2016, then soared by 100.06% to $1.0 in 2017, then soared by 219900.0% to $2200.0 in 2018, then slumped by 4824.14% to -$103931.0 in 2019, then jumped by 98.27% to -$1800.0 in 2020.
- According to Business Quant data, Change in Inventory over the past three periods registered -$1800.0, -$263.0, and -$103931.0 for Q3 2020, Q1 2020, and Q4 2019 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 27.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 28.20 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 132.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 47.15 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -280,000.00 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 135.26 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 12.97 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Sigyn Therapeutics | 48,161.31 | -37,409.69 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | -1,800.00 |
| Sep 30, 2020 | -1,800.00 |
| Mar 31, 2020 | -263.00 |
| Mar 31, 2020 | -263.00 |
| Dec 31, 2019 | -103,931.00 |
| Dec 31, 2019 | -103,931.00 |
| Sep 30, 2019 | -7,560.00 |
| Sep 30, 2019 | -7,560.00 |
| Jun 30, 2019 | -15,750.00 |
| Jun 30, 2019 | -15,750.00 |
| Mar 31, 2019 | -8,244.00 |
| Mar 31, 2019 | -8,244.00 |
| Sep 30, 2018 | 2,200.00 |
| Sep 30, 2018 | 2,200.00 |
| Jun 30, 2018 | -1.00 |
| Jun 30, 2018 | -1.00 |
| Mar 31, 2018 | -4,744.00 |
| Mar 31, 2018 | -4,744.00 |
| Dec 31, 2017 | 1.00 |
| Dec 31, 2017 | 1.00 |